MacroChem Announces Phase 2 Data For EcoNail(R) In The Treatment Of Onychomycosis

MacroChem Corporation (OTC Bulletin Board: MACM) announced results of a Phase 2 clinical trial involving 37 patients who completed a 48-week, U.S. multi-center, open-label efficacy and safety study of EcoNail, a topical antifungal lacquer for the treatment of onychomycosis (nail fungus).

More: continued here

Filed under: Dermatology on July 25th, 2008